International uniform response criteria for multiple myeloma
Brian G.M. Durie(Cedars-Sinai Medical Center), Pieter Sonneveld(Erasmus MC Cancer Institute), Guido Tricot, Raymond Alexanian(The University of Texas MD Anderson Cancer Center), Morie A. Gertz(Medical University of South Carolina), Andrew Belch, Jesús F. San Miguel(Clinica Universidad de Navarra), Robert A. Kyle(Mayo Clinic), Patrizia Tosi(Azienda Unità Sanitaria Locale Della Romagna), M Boccadaro(University of Turin), Michel Attal(Université Fédérale de Toulouse Midi-Pyrénées), Heinz Ludwig(Wilhelminen Hospital), Ingemar Turesson(Spanish Head & Neck Cancer Cooperative Group), Kenneth C. Anderson(Dana-Farber Cancer Institute), Meral Beksaç(Ankara University), Meletios Α. Dimopoulos(Korea University), Paul G. Richardson(Harvard University), Gösta Gahrton(Karolinska Institutet), S. Vincent Rajkumar(WinnMed), Giampaolo Merlini(University of Pavia), Gareth J. Morgan(Hywel Dda University Health Board), Kazuyuki Shimizu(Spanish Head & Neck Cancer Cooperative Group), D. Joshua(Royal Prince Alfred Hospital), J-L Harousseau, Jan Westin(Spanish Head & Neck Cancer Cooperative Group), John Crowley(AbbVie (United States)), R Powles(Myeloma UK), J Bladé(Hospital Clínic de Barcelona), Bart Barlogie(University of Arkansas for Medical Sciences), David H. Vesole(Hackensack University Medical Center)
Cited by 2,636
Related Papers
The Global Syndemic of Obesity, Undernutrition, and Climate Change: The Lancet Commission report
|The Lancet|2019|3k
International Staging System for Multiple Myeloma
|Journal of Clinical Oncology|2005|2.9k
A Phase 2 Study of Bortezomib in Relapsed, Refractory Myeloma
|New England Journal of Medicine|2003|2.6k
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k